Effects of mechanochemically activated doxorubicin and 40 MHz frequency irradiation on human A-549 lung carcinoma cells

Experimental Oncology

Volumn 26, Issue 4, 2004, Pages 271-277

  Orel, V E ^a   Kudryavets, Yu I ^b   Satz, S ^c   Bezdenezhnih, N A ^b   Danko, M I ^a   Khranovskaya, N N ^a   Romanov, A V ^a   Dzyatkovskaya, N N ^a   Burlaka, A P ^b   Sidorik, E P ^b  

^a STATE INSTITUTION NATIONAL RESEARCH CENTER FOR RADIATION MEDICINE OF THE NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE   (Ukraine)

^b R E KAVETSKY INSTITUTE OF EXPERIMENTAL PATHOLOGY   (Ukraine)

^c BioNucleonics Inc   (United States)

Author keywords

A 549 human lung carcinoma cells; Doxorubicin; Electromagnetic irradiation; Mechanochemical activation

Indexed keywords

DOXORUBICIN; FREE RADICAL; ANTHRACYCLINE; ANTINEOPLASTIC AGENT; QUINONE DERIVATIVE;

ARTICLE; CANCER CELL CULTURE; CELL ASSAY; CELL SURVIVAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVATION; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG TARGETING; ELECTROMAGNETIC FIELD; ELECTROMAGNETIC RADIATION; ELECTRON MICROSCOPY; ELECTRON SPIN RESONANCE; ENERGY; FLOW CYTOMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; LD 50; LUNG CARCINOMA; MITOSIS INHIBITION; OUTCOMES RESEARCH; PARAMETER; PARTICLE SIZE; SOLID STATE; TEMPERATURE; CANCER CELL; CANCER SURVIVAL; DRUG EFFECT; FREQUENCY ANALYSIS; INCUBATION TEMPERATURE; IRRADIATION; QUANTITATIVE ANALYSIS;

ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA; DOXORUBICIN; DRUG DELIVERY SYSTEMS; ELECTROMAGNETIC FIELDS; FRICTION; HUMANS; LUNG NEOPLASMS; PARTICLE SIZE; TEMPERATURE; TUMOR CELLS, CULTURED;

EID: 19944432248     PISSN: 02043564     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Bachur NB. Anthracycline antibiotic pharmacology and metabolism. Cancer Treat Rep 1979; 63: 81725.
2. Reszka KJ, Mc Cormick ML, Britigan BE. Peroxidase- and nitrite-dependent metabolism of the anthracycline anticancer agents daunorubiciu and doxorabicin. Biochemistry 2001; 40: 15349-61.
3. Shao J, DeHaven J, Lamm D, Runyan K, Malanga CJ, Rojanasakul Y, Ma JKH. A cell-based drug delivery system for lung targeting: 1. Preparation and pharmacokinetics. Drug Delivery 2001; 8: 61-9.
4. Pacilio C, Florio S, Pagnini U, Crispino A, Claudio PP, Pacilio G, Pagnini G. Modification of membrane fluidity and depolarization by some anthracyclines in different cells lines. Anticancer Res 1998; 18: 4027-34.
5. Hirata M, Kusuzaki K, Takeshita H, Hashiguchi S, Hirasawa Y, Ashichara T. Drug resistance modification using electromagnetic field stimulation for multidrug resistant mouse osteosarcoma cell line. Anticancer Res 2001; 21: 317-32.
6. Pasquinelli P, Petrini M, Mattii L, Galimberti S, Saviozzi M, Malvaldi G. Biological effects of PEMF (pulsing electromagnetic field): an attempt to modify cell resistance to anticancer agents. J Environ Pathol Toxicol Oncol 1993; 12:193-7.
7. Marmor JB. Interactions of hyperthermia and chemotherapy in animals. Cancer Res 1979; 39: 2269-76.
8. Au JL, Jang SH, Zheng J, Chen C, Song SHL, Wientjes MG. Determinants of drug delivery and transport to solid tumors. J Control Release 2001; 74: 31-46.
9. Kondo SA. Design and development of novel polymeric prodrugs prepared by mechanochemical solid-state polymerization. Yakugaku Zasshi 2000; 120: 1337-46.
10. Todor IN, Orel VE, Mikhailenko VM, Danko MI, Dzyatkovskaya NN. Influence of mechanochemically modified doxorubicin and irradiation with frequency 40 MHz on doxorubicin-resistant Guerin's carcinoma. Exp Oncol 2002; 24: 234-6.
11. Medinets YuR, Orlovskiy AA. Magnetothermia - therapeutic heating in magnetic field of high frequency. Med Physics 2003; 17: 67-74 (In Russian).
12. The United States Pharmacopoeia The National Formulary. USP XXII NF XVII. United States Pharmacopeial Convention, 1990; INC: 478.
13. Losa GA. Fractal in pathology: are they really useful? Pathologica 1995; 87: 310-7.
14. Losa GA. Fractal morphometry of cell complexity. Rev Biol 2002; 95: 239-58.
15. Frieser H. Photographic information recording. London: Focal Press, 1975; 237 p.
16. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Meth 1991; 139: 271-9.
17. Merkel DE, Mc Guire WL. Ploidy, proliferative activity and prognosis: DNA flow cytometry of solid tumors. Cancer 1990; 65: 1194-205.
18. Mimnaugh EG, Kennedy KA, Trush MA, Sinha BK. Adriamycin-enhanced membrane lipid peroxidation in isolated rat nuclei. Cancer Res 1985; 45: 3296-304.
19. Heinike G. Tribochemistry. Berlin: Akademia-Verlag, 1984.
20. Kalinina YeV, Saprin AN, Solomka VS, Sherbak NP, Piruzyan LA. Inhibition of hydrogen peroxide, oxygen and semiquione radicals in the course of formation of resistance of human erytroleukemia K562 cells to doxorubicin. Problems Oncol 2003; 49: 294-8.
21. Praet M, Calderon PB, Pollakis G, Roberfroid M, Ruysschaert JM. A new class of free radical scavengers reducing adriamycin mitochondrial toxicity. Biochem Pharmacol 1988; 37: 4617-22.
22. Ahammer H, Devaney TTJ, Tritthart HA. Fractal dimension for a cancer invasion model. Fractals 2001; 9: 61-76.
23. Rudge S, Peterson C, Vessely C, Koda J, Stevens S, Catterall L. Adsorption and desorption of chemotherapeutic drugs from a magnetically targeted carrier (MTC). J Control Release 2001; 74: 335-40.
24. Studzian K, Wasowska M, Piestrzenieicz MK, Wilmanska D, Szmigiero L, Oszczapowicz I, Giniazddowski M. Inhibition of RNA synthesis in vitro and cell growth by anthracycline antibiotics. Neoplasma 2001; 48: 412-8.
25. Eliaz E, Rom N, Shlomo MC, Szoka FC. Determination and modeling of kinetics of cancer cell killing by doxorubicin and doxorubicin encapsulated in targeted liposomes. Cancer Res 2004; 64: 711-8.
26. Bezrukov SM, Vodyanoy I. Signal transduction across alamethicin ion channels in the presence of noise. Biophys J 1997; 73: 2456-64.
27. Blanchard JP, Blackman CF. Clarification and application of an ion paramagnetic resonance model for magnetic field interactions with biological resonance systems. Bioelectromagnetics 1994; 15: 217-38.
28. Liboff AR. Cyclotron resonance in membrane transport. In: Interaction between electromagnetic field and cells. Chiabrera A, Nicolini C, Schwan HP, eds. New York: Plenum, 1985: 281-96.
29. Hortobagyi GN. Anthracyclines in the treatment of cancer. Drugs 1997; 54: 1-14.
30. Patel S, Sprung AU, Keller BA., Heaton VJ, Fisher LM. Identification of yeast DNA topoisomerase II mutants resistant to the antitumor drug doxombicin: implications for the mechanisms of doxorubicin action and cytotoxicity. Mol Pharmacol 1997; 52: 658-66.